Mereo BioPharma (MREO) Change in Account Payables (2023 - 2026)
Mereo BioPharma (MREO) posted quarterly Change in Account Payables of $2.0 million for Q1 2026, up 440.61% year-on-year from $362000.0 in Q1 2025, and up 337.81% on a QoQ basis from $447000.0 in Q4 2025.
Mereo BioPharma (MREO) Change in Account Payables (2023 - 2026) Analysis & Trends
Mereo BioPharma (MREO) has reported Change in Account Payables for 4 consecutive years, with $2.0 million the latest figure, recorded in Q1 2026.
- Quarterly Change in Account Payables rose 440.61% year-over-year to $2.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $217000.0 (down 43.04% YoY) and the FY2025 annual result came in at -$1.4 million, down 1043.84% from the prior year.
- Change in Account Payables rose to $2.0 million in Q1 2026 per MREO's latest filing, from $447000.0 in the prior quarter.
- Over the last five years, Change in Account Payables for MREO reached as high as $2.0 million in Q1 2026 and fell as low as -$2.3 million in Q2 2023.
- A 4-year average of -$41384.6 and a median of $241000.0 in 2024 frame the typical range for Change in Account Payables.
- Annual changes were most pronounced in 2025 — Change in Account Payables plunged 909.54% — and 2026, when it soared 440.61%.
- Year by year, Change in Account Payables stood at $987000.0 in 2023, then dropped by 14.59% to $843000.0 in 2024, then plunged by 46.98% to $447000.0 in 2025, then jumped by 337.81% to $2.0 million in 2026.
- According to Business Quant data, Change in Account Payables over the past three periods registered $2.0 million, $447000.0, and -$236000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -42.19 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.52 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 35.60 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.86 Mn |
| 10 | Mereo BioPharma | 232.52 Mn | 232.52 Mn | - | 1.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.96 Mn |
| Mar 31, 2026 | 1.96 Mn |
| Dec 31, 2025 | 447,000.00 |
| Dec 31, 2025 | 447,000.00 |
| Sep 30, 2025 | -236,000.00 |
| Sep 30, 2025 | -236,000.00 |
| Jun 30, 2025 | -1.95 Mn |
| Jun 30, 2025 | -1.95 Mn |
| Mar 31, 2025 | 362,000.00 |
| Mar 31, 2025 | 362,000.00 |
| Dec 31, 2024 | 843,000.00 |
| Dec 31, 2024 | 843,000.00 |
| Sep 30, 2024 | -1.07 Mn |
| Sep 30, 2024 | -1.07 Mn |
| Jun 30, 2024 | 241,000.00 |
| Jun 30, 2024 | 241,000.00 |
| Mar 31, 2024 | 127,000.00 |
| Mar 31, 2024 | 127,000.00 |
| Dec 31, 2023 | 987,000.00 |
| Dec 31, 2023 | 987,000.00 |